António Marinho Selected Research

António Marinho Research Topics

Disease

5	Inflammation (Inflammations) 06/2022 - 01/2017
5	Systemic Lupus Erythematosus (Libman-Sacks Disease) 11/2021 - 04/2009
5	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 01/2012
3	Rheumatoid Arthritis 06/2022 - 01/2015
3	Vasculitis (Vasculitides) 01/2021 - 10/2013
3	Infections 02/2020 - 04/2009
2	Lupus Nephritis 11/2021 - 08/2021
2	Myositis (Idiopathic Inflammatory Myopathies) 01/2021 - 01/2012
2	Sarcoidosis (Schaumann Disease) 02/2020 - 06/2015
1	Cardiac Tamponade 12/2022
1	Bruton type agammaglobulinemia 12/2022
1	Pericarditis 12/2022
1	Diarrhea 12/2022
1	Chest Pain (Chest Pains) 12/2022
1	Prurigo 01/2022
1	Ventricular Dysfunction 03/2021
1	Clinical Deterioration 01/2021
1	Anemia 01/2021
1	Tenosynovitis 01/2021
1	Hemorrhage 01/2021
1	Neoplasms (Cancer) 02/2020
1	Cryptococcal Meningitis 02/2020
1	Encephalitis (Encephalitis, Rasmussen) 02/2020
1	Autoimmune Diseases of the Nervous System 02/2020
1	Granuloma 01/2020
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2020
1	Aortic Coarctation 01/2019
1	Vitamin D Deficiency 01/2018
1	Disease Progression 01/2017
1	Tuberculosis (Tuberculoses) 06/2015
1	Respiratory Insufficiency (Respiratory Failure) 04/2015
1	Systemic Scleroderma (Systemic Sclerosis) 01/2015
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2015
1	Psoriatic Arthritis 01/2015
1	Myasthenia Gravis 01/2015
1	Multiple Sclerosis 01/2015
1	Muscular Diseases (Myopathy) 07/2014
1	Glycogen Storage Disease Type II (Pompe's Disease) 07/2014
1	Systemic Vasculitis 10/2013
1	X-Linked Emery-Dreifuss Muscular Dystrophy 03/2012
1	Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy) 03/2012
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2012
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2012
1	Liver Diseases (Liver Disease) 01/2012
1	Erdheim-Chester Disease 03/2011
1	Nephritis 09/2009
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 09/2009
1	Chronic Disease (Chronic Diseases) 04/2009

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2019
4	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2021 - 10/2013
3	Proteins (Proteins, Gene)FDA Link 06/2022 - 03/2012
3	Vitamin D FDA LinkGeneric 01/2018 - 01/2017
3	AutoantibodiesIBA 01/2017 - 04/2009
2	Rituximab (Mabthera)FDA Link 01/2021 - 04/2015
2	AntibodiesIBA 02/2020 - 01/2012
2	AutoantigensIBA 01/2017 - 01/2017
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2015 - 09/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2022
1	AdipokinesIBA 06/2022
1	Biological ProductsIBA 06/2022
1	C-Reactive ProteinIBA 06/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2022
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 06/2022
1	LeptinIBA 06/2022
1	dupilumabIBA 01/2022
1	Polysaccharides (Glycans)IBA 11/2021
1	secukinumabIBA 08/2021
1	Receptor Activator of Nuclear Factor-kappa B (TRANCE-R)IBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 01/2021
1	obinutuzumabIBA 01/2021
1	Growth Differentiation Factor 2IBA 01/2021
1	AdrenomedullinIBA 01/2021
1	PTX3 proteinIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2021
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021
1	Methylprednisolone FDA LinkGeneric 01/2021
1	Prostaglandins FIBA 01/2021
1	TroponinIBA 01/2021
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 02/2020
1	hydroxide ionIBA 01/2018
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2017
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2015
1	GlucosidasesIBA 07/2014
1	AcidsIBA 07/2014
1	Propylthiouracil FDA Link 10/2013
1	emerinIBA 03/2012
1	InterferonsIBA 03/2011
1	Antiphospholipid AntibodiesIBA 09/2009

Therapy/Procedure

2	Therapeutics 01/2021 - 04/2009
1	Plasmapheresis 01/2021
1	Stents 01/2019
1	Aftercare (After-Treatment) 06/2015